Clinical Trial Update: Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating finerenone's impact on cardio-renal target organ damage in patients with type 2 diabetes mellitus and chronic kidney disease due to t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Chronic Kidney Disease Due to Type Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Finerenone (finerenone)

Snippet

Sponsor: University of Aarhus | Conditions: Type 2 Diabetes Mellitus (T2DM), Chronic Kidney Disease Due to Type 2 Diabetes Mellitus | Phase 4 | Status: RECRUITING